Crossmark

Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection

Crossref DOI link: https://doi.org/10.1186/s12876-020-01459-w

Published Online: 2020-09-25

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ueda, Naoyuki

Kawaoka, Tomokazu http://orcid.org/0000-0001-5113-4031
Imamura, Michio

Aikata, Hiroshi

Nakahara, Takashi

Murakami, Eisuke

Tsuge, Masataka

Hiramatsu, Akira

Hayes, C. Nelson

Yokozaki, Michiya

Chayama, Kazuaki
Funding

Funding for this research was provided by:

Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED (18fk0210020h0002)
License Information

Text and Data Mining valid from 2020-09-25

Version of Record valid from 2020-09-25
More Information

Article History

Received: 29 January 2020

Accepted: 17 September 2020

First Online: 25 September 2020

Ethics approval and consent to participate

: The study was carried out in accordance with the ethical guidelines of the Declaration of Helsinki and approved by the ethics and research committees of Hiroshima University Hospital (Hiroshima, Japan: no. E-946). Informed consent was obtained from each patient in writing.

: Not applicable.

: Kazuaki Chayama has received honoraria from Bristol-Myers Squibb and MSD K.K. and research funding from Dainippon Sumitomo Pharma and AbbVie. Michio Imamura has received research funding from Bristol-Myers Squibb.

Document is current

Any future updates will be listed below